Literature DB >> 1376254

Functional characterization of non-human primate erythrocyte immune adherence receptors: implications for the uptake of immune complexes by the cells of the mononuclear phagocytic system.

J C Edberg1, R P Kimberly, R P Taylor.   

Abstract

Erythrocytes from primates express an immune adherence (IA) receptor that binds complement-opsonized immune complexes (IC) both in vivo and in vitro. We have analyzed the immunochemical and functional properties of the IA receptor from erythrocytes from species that have been used for in vivo IC clearance studies and have compared these properties to the human IA receptor (which is called complement receptor type 1, CR1). Erythrocytes from all species (chimpanzee, baboon, rhesus and cynomolgus monkey) bind antibody/double-stranded DNA IC when opsonized with autologous complement. However, IC which are bound to chimpanzee erythrocytes are not released upon addition of chimpanzee serum (which contains factor I activity), while IC bound to baboon erythrocytes and human erythrocytes are released upon addition of autologous serum. Anti-human CR1 monoclonal antibodies (mAb) E11 and HB8592 bind to erythrocytes from all species examined and the number of mAb epitopes per erythrocyte correlated with the number of IC that could bind to the erythrocyte under saturating conditions. However, a number of interesting differences between the species are observed with other mAb. The anti-CR1 mAb 1B4 and 3D9, which block recognition of ligand by CR1, did not bind to chimpanzee erythrocytes and bound partially to rhesus and cynomolgus monkey erythrocytes. In addition, the ability of autologous serum to induce release of erythrocyte-bound IC correlates with the presence of these epitopes. These findings, taken in context with previous clearance studies, suggest that serum-mediated release may not be required for the rapid transfer of the IC from the erythrocyte to the mononuclear phagocytic system.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1376254     DOI: 10.1002/eji.1830220602

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  4 in total

1.  Effect of plasmapheresis on ligand binding capacity and expression of erythrocyte complement receptor type 1 (CR1) of patients with systemic lupus erythematosus (SLE).

Authors:  I Csípö; E Kiss; P Soltész; P Antal-Szalmás; G Szegedi; J H Cohen; R P Taylor; M Kávai
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

2.  Soluble complement receptor type 1 (sCR1) in chronic liver diseases: serum levels at different stages of liver diseases.

Authors:  D Di Bona; G Montalto; L Clemenza; F Bascone; P Accardo; D Bellavia; A Craxì; M Brai
Journal:  Clin Exp Immunol       Date:  1998-10       Impact factor: 4.330

3.  Characterization of the mechanism of protection mediated by CS-D7, a monoclonal antibody to Staphylococcus aureus iron regulated surface determinant B (IsdB).

Authors:  Gregory Pancari; Hongxia Fan; Sharon Smith; Amita Joshi; Robin Haimbach; Desmond Clark; Yingzhe Li; Jin Hua; Troy McKelvey; Yangsi Ou; James Drummond; Leslie Cope; Donna Montgomery; Tessie McNeely
Journal:  Front Cell Infect Microbiol       Date:  2012-03-20       Impact factor: 5.293

4.  A primate model of severe malarial anaemia: a comparative pathogenesis study.

Authors:  Amber I Raja; Elizabeth B Brickley; Jessica Taaffe; Timmy Ton; Zhen Zhao; Kevin W Bock; Sachy Orr-Gonzalez; Marvin L Thomas; Lynn E Lambert; Ian N Moore; Patrick E Duffy
Journal:  Sci Rep       Date:  2019-12-12       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.